Higher Intensity Statin Therapy Reduces Clinical Endpoints after Heart Transplantation Independent of Lipid Levels

Coronary artery disease is a leading cause of morbidity and mortality after heart transplantation (HT), resulting from cardiovascular risk factors and those associated with a proinflammatory state. Statins reduce incidence of post-HT cardiac allograft vasculopathy (CAV); it is unknown whether they act through their lipid-lowering effects or through alternative mechanisms.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 163 Source Type: research